ROC analysis showed SNHG9 has high sensitivity and specificity for identification of hepatoblastoma tumors, thus it could be a potential diagnostic biomarker, and therapeutic target for the treatment and early diagnosis of HB patients. This evidence concerns the gene SNHG9 and hemoglobin measurement.